NO20013632L - Steroid sulfatase inhibitorer og fremgangsmater for fremstilling og anvendelse av det samme - Google Patents

Steroid sulfatase inhibitorer og fremgangsmater for fremstilling og anvendelse av det samme

Info

Publication number
NO20013632L
NO20013632L NO20013632A NO20013632A NO20013632L NO 20013632 L NO20013632 L NO 20013632L NO 20013632 A NO20013632 A NO 20013632A NO 20013632 A NO20013632 A NO 20013632A NO 20013632 L NO20013632 L NO 20013632L
Authority
NO
Norway
Prior art keywords
methods
preparation
same
steroid sulfatase
sulfatase inhibitors
Prior art date
Application number
NO20013632A
Other languages
English (en)
Other versions
NO318836B1 (no
NO20013632D0 (no
Inventor
Pui-Kai Li
Shiro Akinaga
Chikara Murakata
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO20013632D0 publication Critical patent/NO20013632D0/no
Publication of NO20013632L publication Critical patent/NO20013632L/no
Publication of NO318836B1 publication Critical patent/NO318836B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073—Sulfur-containing hetero ring
    • C07J71/0094—Sulfur-containing hetero ring containing sulfur and nitrogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20013632A 1999-01-25 2001-07-24 Steroidsulfataseinhibitorer og anvendelse av det samme NO318836B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/236,842 US6288050B1 (en) 1997-07-18 1999-01-25 Steroid sulfatase inhibitors and methods for making and using the same
PCT/US2000/001723 WO2000043408A2 (en) 1999-01-25 2000-01-24 Steroid sulfatase inhibitors and methods for making and using the same

Publications (3)

Publication Number Publication Date
NO20013632D0 NO20013632D0 (no) 2001-07-24
NO20013632L true NO20013632L (no) 2001-09-03
NO318836B1 NO318836B1 (no) 2005-05-09

Family

ID=22891204

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013632A NO318836B1 (no) 1999-01-25 2001-07-24 Steroidsulfataseinhibitorer og anvendelse av det samme

Country Status (16)

Country Link
US (2) US6288050B1 (no)
EP (1) EP1147124B1 (no)
JP (1) JP3913475B2 (no)
KR (1) KR20010108127A (no)
CN (1) CN1159337C (no)
AT (1) ATE338056T1 (no)
AU (1) AU768677C (no)
BR (1) BR0008437A (no)
CA (1) CA2361168A1 (no)
DE (1) DE60030410T2 (no)
ES (1) ES2272256T3 (no)
HU (1) HUP0200096A3 (no)
MX (1) MXPA01007506A (no)
NO (1) NO318836B1 (no)
NZ (1) NZ512923A (no)
WO (1) WO2000043408A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476011B1 (en) * 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
JP2000309599A (ja) * 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
AU2001248849A1 (en) 2000-04-24 2001-11-07 Kyowa Hakko Kogyo Co. Ltd. Estra-1,3,5(10)-triene derivatives
EP1364643A4 (en) * 2000-12-01 2009-07-15 Kyowa Hakko Kogyo Kk COMPOSITION WITH IMPROVED ORAL SOLUBILITY OR ABSORBABILITY
US8026229B2 (en) * 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
WO2003039466A2 (en) * 2001-11-06 2003-05-15 Applied Research Systems Ars Holding N.V. Method of treating estrogen responsive breast cancer
AU2002342163B2 (en) * 2001-11-06 2007-11-08 Laboratoires Serono Sa Methods of treating endometreosis
US20040042416A1 (en) * 2002-08-27 2004-03-04 Ngo Chuong Ngoc Virtual Local Area Network auto-discovery methods
JPWO2004035089A1 (ja) * 2002-10-09 2006-02-09 協和醗酵工業株式会社 ホルモン依存性癌の治療剤
EP1608671B1 (en) * 2003-03-24 2010-01-06 Sterix Limited Oestrogen derivatives as inhibitors of steroid sulphatase
GB0306717D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
WO2005095437A1 (ja) * 2004-03-30 2005-10-13 Kyowa Hakko Kogyo Co., Ltd. ステロイド誘導体の製造法
JP6431538B2 (ja) 2013-11-21 2018-11-28 マーケット ユニバーシティー エストロゲン受容体ベータアイソフォームの選択的アゴニストとしての置換（４’−ヒドロキシフェニル）シクロアルカン化合物およびその使用
EP3873479A4 (en) * 2018-11-01 2022-08-03 The Regents of the University of California COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF ANDROGEN MEDIATED DISEASE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE86393C (no)
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9118465D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5556847A (en) 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5571933A (en) 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5567831A (en) 1995-08-16 1996-10-22 Duguesne University Of The Holy Ghost Non-steroidal sulfatase inhibitor compounds and their method of use
DE19540233B4 (de) * 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US5763492A (en) 1996-10-01 1998-06-09 Duguesne University Of The Holy Ghost Methods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitors
US5763432A (en) 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6046186A (en) * 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use

Also Published As

Publication number Publication date
HUP0200096A3 (en) 2003-01-28
CN1159337C (zh) 2004-07-28
US6399595B1 (en) 2002-06-04
MXPA01007506A (es) 2003-06-24
DE60030410D1 (de) 2006-10-12
AU2625900A (en) 2000-08-07
DE60030410T2 (de) 2007-08-30
NZ512923A (en) 2003-01-31
NO318836B1 (no) 2005-05-09
CA2361168A1 (en) 2000-07-27
NO20013632D0 (no) 2001-07-24
EP1147124A2 (en) 2001-10-24
KR20010108127A (ko) 2001-12-07
CN1340056A (zh) 2002-03-13
JP2002535340A (ja) 2002-10-22
HUP0200096A2 (hu) 2002-07-29
US6288050B1 (en) 2001-09-11
AU768677B2 (en) 2003-12-18
EP1147124B1 (en) 2006-08-30
ATE338056T1 (de) 2006-09-15
ES2272256T3 (es) 2007-05-01
WO2000043408A3 (en) 2000-11-30
JP3913475B2 (ja) 2007-05-09
WO2000043408A2 (en) 2000-07-27
BR0008437A (pt) 2001-10-30
AU768677C (en) 2004-11-11

Similar Documents

Publication Publication Date Title
NO20013632L (no) Steroid sulfatase inhibitorer og fremgangsmater for fremstilling og anvendelse av det samme
EP1009755A4 (en) STEROID SULFATASE INHIBITORS AND METHODS OF PRODUCING AND USING THE SAME
NO20015797D0 (no) Indazolforbindelser og farmasöytiske forbindelser for inhibering av proteinkinaser, og fremgangsmåter til anvendelsederav
AU5276600A (en) Kit for flushing medical devices and method of preparing the flushing solution
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
HUP0101693A3 (en) Use of steroidal sapogenins and their derivatives for producing pharmaceutical compositions for the treatment of alzheimeirs disease
DK1090029T3 (da) 14,15-Cyclopropansteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling, og farmaceutiske præparater indeholdende disse forbindelser
BG107515A (en) Therapeutic combination
AU7994200A (en) Compositions and methods for therapy and diagnosis of prostate cancer
WO2001044247A3 (en) Agents and methods for the treatment of proliferative diseases
NO20021541L (no) 5-beta-sapogenin- og pseudosapogeninderivater samt deres anvendelse ved behandling av demens
ZA200407460B (en) Therapeutic methods and uses of sapogenins and their derivatives
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
NO20030954L (no) Fremgangsmåte for å öke testosteron og beslektede konsentrasjoner av steroid hos kvinner
DE60025848D1 (en) Pyrimidin-derivate als selective inhibitoren von cox-2
NO20053626L (no) Blanding omfattende en kombinasjon av en aromataseinhibitor, et progestin og et ostrogen for anvendelse av behandling av endomeriose
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
AU2112995A (en) Use of estrone derivatives as steroid sulphatase inhibitors
AU2001268233A1 (en) Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
AU2001275707A1 (en) Use of panaxatriol for stimulation angiogenesis
NO20032340D0 (no) Substituerte derivater av aminofuran-2-yl-eddiksyre og aminotien-2-yl-eddiksyre og deres anvendelse for behandling av migrene og smerte
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU2074101A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
NO20025069D0 (no) Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme
HUP0302405A2 (hu) Új benzofuránszármazékok